Hematin

Star0

DB13387InvestigationalSmall molecule

Hematin: Overview.

Formula / weight: C₃₄H₃₃FeN₄O₅ · 633.506 g/mol (avg)

Resolves to

Compound

UNII0WP180G15GCAS15489-90-4ChEBI36161

Structure

InChIKeyBMUDPLZKKRQECS-HXFTUNQESA-KSMILES[OH-].[Fe+3].CC1=C2[N-]C(\C=C3/N=C(/C=C4\[N-]\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O

Targets

P00734F2 P00747PLG

What you can answer from here — as of July 07, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1Structured indicationCondition, population, route and combination as fields, not prose

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Hematin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account